OASIS and PIONEER PLUS Support High-Dose Oral Semaglutide

Higher doses of oral semaglutide (25 mg and 50 mg) seem to be effective in type 2 diabetes and obesity, improving upon results obtained with currently approved maximum dose of oral semaglutide 14 mg daily.
Medscape Medical News

source https://www.medscape.com/viewarticle/993672?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?